MC1770A1 - Composes heterocycliques - Google Patents
Composes heterocycliquesInfo
- Publication number
- MC1770A1 MC1770A1 MC861852A MC1852A MC1770A1 MC 1770 A1 MC1770 A1 MC 1770A1 MC 861852 A MC861852 A MC 861852A MC 1852 A MC1852 A MC 1852A MC 1770 A1 MC1770 A1 MC 1770A1
- Authority
- MC
- Monaco
- Prior art keywords
- methoxy
- chlorophenyl
- methyl
- oxazolyl
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB858525578A GB8525578D0 (en) | 1985-10-17 | 1985-10-17 | Heterocyclic compounds |
| GB868617503A GB8617503D0 (en) | 1985-10-17 | 1986-07-17 | Heterocyclic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MC1770A1 true MC1770A1 (fr) | 1987-07-17 |
Family
ID=26289895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MC861852A MC1770A1 (fr) | 1985-10-17 | 1986-10-15 | Composes heterocycliques |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4774253A (xx) |
| EP (1) | EP0220573B1 (xx) |
| AU (1) | AU594382B2 (xx) |
| CA (1) | CA1287058C (xx) |
| CS (1) | CS255881B2 (xx) |
| DE (1) | DE3682873D1 (xx) |
| DK (1) | DK470886A (xx) |
| ES (2) | ES2002420A6 (xx) |
| FI (1) | FI864052A7 (xx) |
| HU (1) | HU195792B (xx) |
| IL (1) | IL80290A (xx) |
| MC (1) | MC1770A1 (xx) |
| NO (1) | NO167284C (xx) |
| NZ (1) | NZ217871A (xx) |
| PH (1) | PH23022A (xx) |
| PT (1) | PT83565B (xx) |
| SU (1) | SU1514245A3 (xx) |
| ZW (1) | ZW19786A1 (xx) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5149820A (en) * | 1987-03-11 | 1992-09-22 | Norsk Hydro A.S. | Deuterated compounds |
| US5239080A (en) * | 1989-02-08 | 1993-08-24 | Takeda Chemical Industries, Ltd. | Oxazole compounds and their use as antidiabetic and bone-reduction inhibitory agents |
| US5114960A (en) * | 1989-07-20 | 1992-05-19 | Hoffmann-La Roche Inc. | Substituted isoxazole derivatives |
| EP0440183A1 (en) * | 1990-02-01 | 1991-08-07 | Takeda Chemical Industries, Ltd. | Oxazole compounds, their production and use |
| US5348969A (en) * | 1992-04-03 | 1994-09-20 | Bristol-Myers Squibb Company | Diphenyloxazolyl-oxazoles as platelet aggregation inhibitors |
| FR2699172B1 (fr) * | 1992-12-11 | 1995-01-20 | Adir | Nouveaux dérivés de 4-méthyl-1,3-oxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
| US5380738A (en) * | 1993-05-21 | 1995-01-10 | Monsanto Company | 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents |
| ES2125161B1 (es) * | 1996-03-21 | 1999-11-16 | Grupo Farmaceutico Almirall S | Nuevos derivados de 2-(3h)-oxazolona. |
| CA2268394C (en) | 1996-10-14 | 2008-03-25 | Bayer Aktiengesellschaft | New heterocyclylmethyl-substituted pyrazol derivates |
| BR9906312A (pt) * | 1998-03-30 | 2000-07-11 | Japan Tobacco Inc | Método de produção de composto de isoxazolidinadiona |
| HUP0302397A3 (en) * | 2000-05-26 | 2007-02-28 | Nippon Shinyaku Co Ltd | Heterocyclic compounds and pharmaceutical compositions containing them |
| DE60317365T2 (de) * | 2002-11-08 | 2008-08-21 | F. Hoffmann-La Roche Ag | Substituierte 4-alkoxyoxazol derivate als ppar agonisten |
| GB0712653D0 (en) | 2007-06-28 | 2007-08-08 | Syngenta Ltd | Novel herbicides |
| WO2013185976A1 (en) * | 2012-05-03 | 2013-12-19 | Dsm Ip Assets B.V. | A new process for preparation of 4-methyloxazole-5-carboxylic ester |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3401120A (en) * | 1965-10-23 | 1968-09-10 | Gaf Corp | Corrosion inhibitors |
| GB1164510A (en) * | 1967-06-15 | 1969-09-17 | Ici Ltd | Novel Isoxazole Derivatives, the preparation thereof, and Compositions containing the same |
| GB1180268A (en) * | 1967-09-26 | 1970-02-04 | Ici Ltd | Pharmaceutically Active Phenyl-Heterocyclic-Alkanol Derivatives |
| JPS57188587A (en) * | 1981-05-15 | 1982-11-19 | Tanabe Seiyaku Co Ltd | Thienyloxazolylacetic acid derivative and its preparation |
| JPS58183676A (ja) * | 1982-04-19 | 1983-10-26 | Takeda Chem Ind Ltd | オキサゾ−ル誘導体 |
| US4451476A (en) * | 1982-12-13 | 1984-05-29 | Sterling Drug Inc. | Isoxazoles as antiviral agents |
-
1986
- 1986-09-29 ZW ZW197/86A patent/ZW19786A1/xx unknown
- 1986-10-02 DK DK470886A patent/DK470886A/da not_active Application Discontinuation
- 1986-10-07 FI FI864052A patent/FI864052A7/fi not_active Application Discontinuation
- 1986-10-07 CA CA000519957A patent/CA1287058C/en not_active Expired - Lifetime
- 1986-10-09 NZ NZ217871A patent/NZ217871A/xx unknown
- 1986-10-10 DE DE8686114046T patent/DE3682873D1/de not_active Expired - Lifetime
- 1986-10-10 US US06/917,566 patent/US4774253A/en not_active Expired - Fee Related
- 1986-10-10 IL IL80290A patent/IL80290A/xx unknown
- 1986-10-10 EP EP86114046A patent/EP0220573B1/de not_active Expired - Lifetime
- 1986-10-13 AU AU63838/86A patent/AU594382B2/en not_active Ceased
- 1986-10-14 CS CS867415A patent/CS255881B2/cs unknown
- 1986-10-15 HU HU864282A patent/HU195792B/hu not_active IP Right Cessation
- 1986-10-15 MC MC861852A patent/MC1770A1/fr unknown
- 1986-10-15 PH PH34367A patent/PH23022A/en unknown
- 1986-10-16 ES ES8602629A patent/ES2002420A6/es not_active Expired
- 1986-10-16 NO NO864128A patent/NO167284C/no unknown
- 1986-10-16 PT PT83565A patent/PT83565B/pt not_active IP Right Cessation
- 1986-10-16 SU SU864028303A patent/SU1514245A3/ru active
-
1988
- 1988-04-29 ES ES8801315A patent/ES2010537A6/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE3682873D1 (de) | 1992-01-23 |
| EP0220573B1 (de) | 1991-12-11 |
| DK470886D0 (da) | 1986-10-02 |
| US4774253A (en) | 1988-09-27 |
| IL80290A0 (en) | 1987-01-30 |
| PT83565B (pt) | 1989-05-31 |
| PT83565A (en) | 1986-11-01 |
| DK470886A (da) | 1987-04-18 |
| IL80290A (en) | 1990-11-29 |
| NO167284C (no) | 1991-10-23 |
| EP0220573A1 (de) | 1987-05-06 |
| ES2010537A6 (es) | 1989-11-16 |
| FI864052A0 (fi) | 1986-10-07 |
| NO864128L (no) | 1987-04-21 |
| ZW19786A1 (en) | 1988-05-18 |
| PH23022A (en) | 1989-03-03 |
| HUT44245A (en) | 1988-02-29 |
| SU1514245A3 (ru) | 1989-10-07 |
| NO167284B (no) | 1991-07-15 |
| AU594382B2 (en) | 1990-03-08 |
| CA1287058C (en) | 1991-07-30 |
| HU195792B (en) | 1988-07-28 |
| FI864052A7 (fi) | 1987-04-18 |
| NO864128D0 (no) | 1986-10-16 |
| AU6383886A (en) | 1987-04-30 |
| CS741586A2 (en) | 1987-07-16 |
| CS255881B2 (en) | 1988-03-15 |
| NZ217871A (en) | 1990-03-27 |
| ES2002420A6 (es) | 1988-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MC1770A1 (fr) | Composes heterocycliques | |
| FR2471968A1 (fr) | Ethers basiques, leur procede de preparation et compositions pharmaceutiques les contenant | |
| LU81300A1 (fr) | Derives d'hydantoine,procede pour leur preparation et application de ces composes comme medicaments | |
| CH639653A5 (fr) | Aminothiazoles et composition pharmaceutique les contenant. | |
| EP3164393B1 (fr) | Dérivés de flavaglines | |
| EP1525193B1 (fr) | Derives d'acylaminothiazole et leur utilisation comme inhibiteurs de beta-amyloide | |
| US5110831A (en) | Vinylogous hydroxamic acids and derivatives thereof as 5-lipoxygenase inhibitors | |
| LU82334A1 (fr) | Composes de pyranone substitues en position 5 et leur utilisation comme produits pharmaceutiques | |
| CA1267141A (fr) | Esters et amides de l'acide eicosatrynoique et leur application en pharmacie et en cosmetique | |
| EP0418933A1 (fr) | Dérivés d'alcadiènes, leurs préparations, les médicaments les contenant et produits intermédiaires | |
| EP0573318B1 (fr) | Dérivés de l'acide 4-phénylcarbamoyl-3-isoxazolecarboxylique à activité antiinflammatoire | |
| EP0096890B1 (en) | Oxazoleacetic acid derivatives, process for their production and compositions containing said derivatives | |
| JPH08510222A (ja) | 欝病、不安神経症およびパーキンソン病を治療するための１−アリールシクロアルキルスルフィド、スルホキシドおよびスルホン | |
| FR2476071A1 (fr) | Nouveaux acides 2-amino-3-(a-hydroxybenzyl)-phenylacetiques et leurs esters et amides, utiles notamment comme agents anti-inflammatoires, et compositions pharmaceutiques les contenant | |
| FR2568248A1 (fr) | Nouveaux composes naphtaleniques, leur preparation et leur application comme medicaments | |
| EP0037344B1 (fr) | Amino-alcoxy pyrazoles, procédé pour leur préparation, et médicaments les contenant | |
| MC1287A1 (fr) | Derives de cyclohexadiene | |
| MC2105A1 (fr) | Derives de tetrahydronaphtalene | |
| FR2479820A1 (fr) | Compose du type 4-(4-chlorophenyl)-2-(4-acyloxy- ou hydroxyphenyl)-thiazole-5-acetique ou acetate, procede pour sa preparation et son application comme medicament | |
| LU85528A1 (fr) | Aminocyclopentanes et leur procede de preparation | |
| CH648483A5 (fr) | Composition pharmaceutique contre l'arthrite rhumatoide. | |
| JPH02237988A (ja) | イソオキサゾロピリジン系メバロノラクトン類 | |
| FR2632641A1 (fr) | ((aryl-4-piperazinyl-1)-2 ethoxy)-3 p-cymene, les derives ortho, meta, para monosubstitues ou disubstitues sur le noyau phenyle dudit produit, le procede de preparation desdits derives, et les medicaments contenant lesdits composes comme principe actif | |
| WO2012104538A1 (fr) | Nouveaux dérivés de 1, 5 - dihydropyrrol - 2 - one utiles pour le traitement paludisme ou d'autres maladies parasitaires et fongiques | |
| FR2689126A1 (fr) | 2-(imino substitué)-thiazolidines, procédé pour les préparer et utilisation pour la préparation des compositions pharmaceutiques. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| YP | Annual fee paid |